Results 11 to 20 of about 523,804 (280)

Cardiovascular complications of COVID-19

open access: yesHeart and Mind, 2020
Coronavirus disease 19 (COVID-19) has rapidly expanded to a global pandemic, resulting in significant morbidity and mortality. Even though predictors of infection remain unclear, age and preexisting cardiovascular conditions have been clearly identified ...
Joana Brito   +8 more
doaj   +3 more sources

Cardiovascular Complications of COVID-19 Infection

open access: yesActa Médica Portuguesa, 2021
Introduction: Reports of cardiovascular complications related to the COVID-19 infection have been frequent. Methods: Narrative review for relevant articles on the topic.
Maria Ana Trêpa   +2 more
doaj   +1 more source

Cardiovascular Complications in Community-Acquired Pneumonia

open access: yesMicroorganisms, 2022
Community-acquired pneumonia (CAP) is accountable for high mortality in both pediatric and adult populations worldwide, about one-third of hospitalized patients pass away within a year of being discharged from the facility.
Antonio Desai   +4 more
doaj   +1 more source

Cardiovascular Complications of COVID-19 Vaccines

open access: yesFrontiers in Cardiovascular Medicine, 2022
Coronavirus disease 2019 (COVID-19) has become a global public health catastrophe. Vaccination against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is proven to be the most effective measure to suppress the pandemic.
Runyu Liu   +10 more
doaj   +1 more source

Biochemical characterisation of familial hypercholesterolemia: Associations between genetic and lipid profiles [PDF]

open access: yesJournal of Medical Biochemistry
Background: Familial hypercholesterolemia (FH) is characterised by elevated low-density lipoprotein cholesterol (LDL-C) levels and an increased risk of premature cardiovascular disease.
Singh Lukač Sandra   +10 more
doaj   +1 more source

The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms

open access: yesFrontiers in Endocrinology, 2021
Fibroblast growth factor 21 (FGF21), is an emerging metabolic regulator mediates multiple beneficial effects in the treatment of metabolic disorders and related complications.
Mengjie Xiao   +7 more
doaj   +1 more source

Immunophilins and Cardiovascular Complications

open access: yesCurrent Medicinal Chemistry, 2011
Immunophilins belong to a highly conserved family of proteins with cis-trans peptidyl-prolyl isomerase activity, generally classified by their ability to selectively bind specific immunosuppressive drugs, thereby regulating their activity. Immunophilins include Cyclophilins (CyPs), which are specific targets of the immunosuppressant drug cyclosporin A (
Calderón-Sánchez, Eva   +2 more
openaire   +3 more sources

HIV INFECTION AND CARDIOVASCULAR COMPLICATIONS

open access: yesKlinicist, 2014
Due to the increasing number of HIV-infected patients and duration of their survival value for cardiovascular disease complications in the structure of HIV is increasing.
S. S. Yakushin, E. V. Filippov
doaj   +3 more sources

Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetes

open access: yesNature Communications, 2019
Both insulin and IGF-1 signaling have been implicated in arterial intimal hyperplasia. Here the authors dissect the relative contributions of insulin and IGF-1 receptors, showing that homodimers of insulin receptors, but not IGF-1 receptor, induce ...
Qian Li   +11 more
doaj   +1 more source

Cardiovascular Complications of Pregnancy [PDF]

open access: yesInternational Journal of Molecular Sciences, 2015
Pregnancy causes significant metabolic and hemodynamic changes in a woman’s physiology to allow for fetal growth. The inability to adapt to these changes might result in the development of hypertensive disorders of pregnancy (hypertension, preeclampsia or eclampsia), gestational diabetes and preterm birth.
Gongora, Maria Carolina   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy